Stamos Capital Partners, L.P. Gilead Sciences, Inc. Transaction History

Stamos Capital Partners, L.P.

$412 Million
Q3 2024

A detailed history of Stamos Capital Partners, L.P. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Stamos Capital Partners, L.P. holds 32,960 shares of GILD stock, worth $2.97 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

32,960

Previous 43,310 23.9%

Holding current value

$2.97 Million

Previous $2.97 Million 7.03%

% of portfolio

0.67%

Previous 0.65%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $689,206 - $869,296	-10,350 Reduced 23.9%	32,960 $2.76 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $426,262 - $491,939	6,750 Added 18.46%	43,310 $2.97 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $426,616 - $520,248	5,960 Added 19.48%	36,560 $2.68 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $1.08 Million - $1.22 Million	-14,710 Reduced 32.47%	30,600 $2.48 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $64,327 - $70,182	870 Added 1.96%	45,310 $3.4 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $533,590 - $608,634	7,020 Added 18.76%	44,440 $3.42 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $438,347 - $499,413	5,670 Added 17.86%	37,420 $3.1 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $990,888 - $1.42 Million	-15,900 Reduced 33.37%	31,750 $2.73 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $1.57 Million - $1.8 Million	26,450 Added 124.76%	47,650 $2.94 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $1.23 Million - $1.54 Million	21,200 New	21,200 $1.26 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $3.04 Million - $3.47 Million	-50,700 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $2.87 Million - $3.27 Million	50,700 New	50,700 $2.95 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $973,262 - $1.13 Million	-13,454 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $842,624 - $1.08 Million	13,454 New	13,454 $1.01 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $225,036 - $248,400	-3,600 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $222,732 - $249,767	3,600 New	3,600 $244,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stamos Capital Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Stamos Capital Partners, L.P. with notifications on news.

Account

Stamos Capital Partners, L.P. Gilead Sciences, Inc. Transaction History